These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 9820499

  • 1. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
    Fields PE, Finch RJ, Gray GS, Zollner R, Thomas JL, Sturmhoefel K, Lee K, Wolf S, Gajewski TF, Fitch FW.
    J Immunol; 1998 Nov 15; 161(10):5268-75. PubMed ID: 9820499
    [Abstract] [Full Text] [Related]

  • 2. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y, Hiraoka S, Tomura M, Zhou XY, Yashiro-Ohtani Y, Mori Y, Shimizu J, Ono S, Dunussi-Joannopoulos K, Wolf S, Fujiwara H.
    Int Immunol; 2005 Jan 15; 17(1):73-83. PubMed ID: 15569772
    [Abstract] [Full Text] [Related]

  • 3. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN, Sharpe AH.
    J Immunol; 1998 Sep 15; 161(6):2762-71. PubMed ID: 9743334
    [Abstract] [Full Text] [Related]

  • 4. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
    Dubey C, Croft M, Swain SL.
    J Immunol; 1995 Jul 01; 155(1):45-57. PubMed ID: 7541426
    [Abstract] [Full Text] [Related]

  • 5. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H, Cerwenka A, Morgan T, Dutton RW.
    J Immunol; 1999 Aug 01; 163(3):1133-42. PubMed ID: 10415007
    [Abstract] [Full Text] [Related]

  • 6. Costimulatory effect of IL-12 on the activation of naive, memory CD4+ T cells, and Th1 clone.
    Kato T, Morokata T, Igarashi O, Yee ST, Inobe M, Uede T, Azuma M, Okumura K, Nariuchi H.
    Cell Immunol; 1997 Feb 25; 176(1):50-8. PubMed ID: 9070317
    [Abstract] [Full Text] [Related]

  • 7. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
    Hall HT, Petrovic J, Höglund P.
    Eur J Immunol; 2004 Nov 25; 34(11):3091-101. PubMed ID: 15384046
    [Abstract] [Full Text] [Related]

  • 8. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
    Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M.
    J Immunol; 1995 Jan 01; 154(1):97-105. PubMed ID: 7527824
    [Abstract] [Full Text] [Related]

  • 9. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
    Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH.
    J Immunol; 1997 Mar 15; 158(6):2713-22. PubMed ID: 9058805
    [Abstract] [Full Text] [Related]

  • 10. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 15; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 11. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
    Roth R, Nakamura T, Mamula MJ.
    J Immunol; 1996 Oct 01; 157(7):2924-31. PubMed ID: 8816398
    [Abstract] [Full Text] [Related]

  • 12. The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication.
    Barker E, Bossart KN, Fujimura SH, Levy JA.
    Cell Immunol; 1999 Sep 15; 196(2):95-103. PubMed ID: 10527561
    [Abstract] [Full Text] [Related]

  • 13. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X, Constant S, Jorritsma P, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5956-63. PubMed ID: 9550393
    [Abstract] [Full Text] [Related]

  • 14. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I, Weinberg AD, Lemon M, Croft M.
    J Immunol; 1998 Dec 15; 161(12):6510-7. PubMed ID: 9862675
    [Abstract] [Full Text] [Related]

  • 15. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules.
    Natesan M, Razi-Wolf Z, Reiser H.
    J Immunol; 1996 Apr 15; 156(8):2783-91. PubMed ID: 8609397
    [Abstract] [Full Text] [Related]

  • 16. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
    Smythe JA, Fink PD, Logan GJ, Lees J, Rowe PB, Alexander IE.
    J Immunol; 1999 Sep 15; 163(6):3239-49. PubMed ID: 10477593
    [Abstract] [Full Text] [Related]

  • 17. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG, Vendetti S, Bartok I, Schoendorf D, Takacs K, Elliott J, Lechler R, Dyson J.
    J Immunol; 1999 Aug 01; 163(3):1298-305. PubMed ID: 10415027
    [Abstract] [Full Text] [Related]

  • 18. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A, Sent D, Schneider C, Heuser C, Koch D, Pohl C, Seliger B, Abken H.
    Cancer Res; 2001 Mar 01; 61(5):1976-82. PubMed ID: 11280755
    [Abstract] [Full Text] [Related]

  • 19. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C, Bochtler P, Chen L, Schirmbeck R, Reimann J.
    Gastroenterology; 2008 Sep 01; 135(3):980-8. PubMed ID: 18621049
    [Abstract] [Full Text] [Related]

  • 20. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM, Lins DC, Mescher MF.
    J Immunol; 1998 Apr 01; 160(7):3236-43. PubMed ID: 9531279
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.